MY ACCOUNT | NEWSLETTER |

Winnie on wheels keeps rolling after lifesaving cancer treatment at WSU

New university findings highlight potential implications for dogs, cancer, and veterinary practice.


The tumor, later identified as a nephroblastoma, develops from embryonic kidney tissue cells that improperly grow along the spinal cord.

An 8-month-old puppy named Winnie is back home with her family in Spokane after undergoing surgery and completing 20 radiation treatments for a rare spinal tumor at Washington State University’s Veterinary Teaching Hospital.

The American bully now gets around in a custom wheelchair after the cancerous mass damaged her spinal cord, but it has hardly slowed her down.

There was never a time where she was in pain.

At this point, she’s been not walking longer than she ever walked, so she doesn’t even care,” said Jamie Kearney, who co-owns Winnie with her fiancée, Keith Thulon.

The couple first noticed something was wrong when Winnie began walking strangely and started losing control of her back legs.

“She kind of walked like a drunken sailor.

She was just stumbling all over the place,” said Jamie, who just happens to work as an occupational therapy assistant at a rehabilitation facility for spinal cord patients in Spokane.

After the episodes continued, Winnie’s primary veterinarian referred her to WSU, where an MRI revealed a large malignant tumor on her spinal cord.

“It’s almost like they grow a little kidney there, but it’s not functional,” said neurology resident Dr.

At WSU, a team of specialty veterinary surgeons performed a procedure known as a laminectomy to remove as much of the tumor as possible.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Washington State University College of Veterinary Medicine

https://vetmed.wsu.edu/winnie-on-wheels-keeps-rolling-after-lifesaving-cancer-treatment-at-wsu/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease

Like0
Dislike0

Feline tarsal tumours histological spectrum, risk factors and prognostic insights.

Like0
Dislike0

Prevalence of rs850683722 Variant and Its Influence on the Course of Myxomatous Mitral Valve Disease in 105 Cavalier King Charles Spaniel Dogs in the Polish Population.

Like0
Dislike0

Distinct safety profiles of liposomal and conventional irinotecan insights from clinical experience and real-world data.

Like0
Dislike0

Pet Owner Educational Atlas. Diagnosis in Dermatology: A Practical Reference for Veterinary Professionals

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top